A Phase 3 Efficacy and Safety Study of Ataluren (PTC124)

Project: Research project

Project Details

Description

A Phase 3 Efficacy and Safety Study of Ataluren (PTC124) in Patients with Nonsense Mutation Cystic Fibrosis
StatusFinished
Effective start/end date3/20/153/20/16

Funding

  • PTC Therapeutics, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.